However, multiple myeloma patients still have elevated likelihood of dying from nonmyeloma malignancies, CVDs HealthDay Save Recommend Sign in to PracticeUpdate Only registered members have full access to PracticeUpdate content. Further Reading
Prognosis of multiple myeloma patients after autologous stem cell transplantation in the last decade. Comparison of two cohorts with different induction treatment approachesBatlle, MOriol, ALlombart, IMotllo, CGonzalez, YVives, SMoreno, MSancho, J M...
Clinical spectrum and prognosis of multiple myeloma in patients younger than 30 years: Is it different from elderly? JK Science 2006; 8(4): 225-28.Kapoor R, Bansal M, Sastri GJ, et al. Clinical spectrum and prognosis of multiple myeloma in patients younger than 30 years: Is it different...
For patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in BMC Cancer.
Multiple myeloma is the second largest malignant tumor of the blood system. Proteasome inhibitors (PIs) currently are effective drugs for some myeloma patients, but their prognosis varies. We extracted the transcriptome expression data and clinical information of myeloma patients from MMRF CoMMpass data...
How is multiple myeloma diagnosed? For many patients, physicians first suspect multiple myeloma when a routine blood test shows an abnormal amount of protein in the bloodstream or an unusual stickiness of red blood cells causing them to stack up almost like coins in a pattern called rouleaux, an...
SSX cancer testis antigens are expressed in most multiple myeloma patients: co-expression of SSX1, 2, 4, and 5 correlates with adverse prognosis and high f... Cancer testis antigens (CTAs) are tumor-specific antigens that may be useful targets for cancer vaccines. Here, CTA expression was...
The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem cell support: a linkage ... The importance of a sub-region on chromosome 19q13.3 for prognosis of multiple myeloma patients after high-dose treatment and stem ...
Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation. Blood 2008, 112, 4017–4023. [Google Scholar] [CrossRef] [Green Version] Paiva, B.D.L.; Vidriales, M.-B.; Pérez, J.J.; Mateo, G...
For patients with immunoglobulin D multiple myeloma (IgD MM), those with renal impairment (RI) have poorer prognosis and shorter median survival than those with no renal impairment (no-RI), according to a study published online Nov. 23 in Frontiers in On